Peptide- and aptamer-functionalized nanovectors for targeted delivery of therapeutics.
about
Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinicSelf-assembled targeted nanoparticles based on transferrin-modified eight-arm-polyethylene glycol-dihydroartemisinin conjugate.Enhancement of cell recognition in vitro by dual-ligand cancer targeting gold nanoparticlesChitosan-propolis nanoparticle formulation demonstrates anti-bacterial activity against Enterococcus faecalis biofilmsSelection of 2'-deoxy-2'-fluoroarabinonucleotide (FANA) aptamers that bind HIV-1 reverse transcriptase with picomolar affinityHow nanotechnology can enhance docetaxel therapy.Developing U.S. oversight strategies for nanobiotechnology: learning from past oversight experiences.Peptide targeted lipid nanoparticles for anticancer drug delivery.Maintenance of ischemic β cell viability through delivery of lipids and ATP by targeted liposomes.Aptamer-conjugated polymeric nanoparticles for targeted cancer therapy.Formulation and physiologic factors affecting the pharmacology of carrier-mediated anticancer agents.Peptides, polypeptides and peptide-polymer hybrids as nucleic acid carriers.PLA-PEG-PLA copolymer-based polymersomes as nanocarriers for delivery of hydrophilic and hydrophobic drugs: preparation and evaluation with atorvastatin and lisinopril.The bench scientist’s perspective on the unique considerations in nanoparticle regulation
P2860
Q33911056-AC4A3F1B-4CD9-41FF-B88A-7C600BEB9BD7Q34532926-10C09F7F-B9F9-4092-8B9F-413CAABFC078Q34573279-2BAC4A01-BF7A-4FB0-B35D-D046E3CF6BCCQ36330299-C9F1DDC4-C94E-49F6-A682-D37929BBC64DQ36575322-E0F1A3E6-D4C2-497C-B7F7-36ACB7851CB1Q37091683-CFD37602-EFED-4B28-A70E-7E0C67BA11CCQ37685273-A5FABDC4-20F5-4C11-AE19-CF95AD802D65Q38016810-4AEA1ACE-EF29-4DF3-A2C5-F294D4DA8176Q38287536-B5FCEC79-4EA7-4D4E-8FEC-8E729293A026Q38383216-BE2F94A9-0852-41BA-815D-DFAB96985300Q38546964-89796EE4-B645-40B9-B848-E4F8899373B0Q40054028-66F263D0-9877-4B4D-B7AB-4BEBC6B2447FQ43501935-0FF267AC-98BF-43D2-A3DB-A246C57D2777Q57425326-2C83ECC8-72BA-4521-BB84-0CB5B71008E4
P2860
Peptide- and aptamer-functionalized nanovectors for targeted delivery of therapeutics.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Peptide- and aptamer-functionalized nanovectors for targeted delivery of therapeutics.
@en
Peptide- and aptamer-functionalized nanovectors for targeted delivery of therapeutics.
@nl
type
label
Peptide- and aptamer-functionalized nanovectors for targeted delivery of therapeutics.
@en
Peptide- and aptamer-functionalized nanovectors for targeted delivery of therapeutics.
@nl
prefLabel
Peptide- and aptamer-functionalized nanovectors for targeted delivery of therapeutics.
@en
Peptide- and aptamer-functionalized nanovectors for targeted delivery of therapeutics.
@nl
P2093
P2860
P356
P1476
Peptide- and aptamer-functionalized nanovectors for targeted delivery of therapeutics
@en
P2093
Brett Waybrant
Maroof M Adil
Matthew A Petersen
Todd O Pangburn
P2860
P304
P356
10.1115/1.3160763
P577
2009-07-01T00:00:00Z